HK Stock MarketDetailed Quotes

INNOCARE (09969)

Watchlist
  • 12.940
  • -0.080-0.61%
Market Closed Jan 16 16:08 CST
22.80BMarket Cap-90.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INNOCARE (09969) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Turnover
59.85%1.12B
74.26%731.43M
129.92%381.26M
36.68%1.01B
29.85%697.75M
11.17%419.74M
-12.44%165.82M
18.09%738.54M
21.68%537.36M
53.50%377.55M
Operating income
59.85%1.12B
74.26%731.43M
129.92%381.26M
36.68%1.01B
29.85%697.75M
11.17%419.74M
-12.44%165.82M
18.09%738.54M
21.68%537.36M
53.50%377.55M
Cost of sales
----
-27.56%-76.71M
----
-7.79%-138.44M
----
20.94%-60.14M
----
10.43%-128.44M
----
-21.25%-76.07M
Operating expenses
-27.70%-125.18M
-27.56%-76.71M
-48.48%-36.07M
-7.79%-138.44M
2.83%-98.03M
20.94%-60.14M
43.38%-24.29M
10.43%-128.44M
-1.16%-100.88M
-21.25%-76.07M
Gross profit
65.10%990.15M
82.07%654.72M
143.90%345.2M
42.76%871.01M
37.40%599.72M
19.28%359.6M
-3.38%141.53M
26.58%610.1M
27.67%436.48M
64.54%301.48M
Selling expenses
-40.77%-385.6M
-55.31%-244.07M
-27.34%-114.01M
-14.46%-419.96M
-2.48%-273.93M
17.81%-157.15M
-4.15%-89.53M
16.35%-366.89M
7.91%-267.3M
-2.77%-191.21M
Administrative expenses
-3.33%-130M
-3.55%-94.76M
-0.83%-42.76M
4.99%-183.86M
1.66%-125.82M
-4.82%-91.51M
-14.89%-42.41M
-6.59%-193.52M
-5.78%-127.94M
-11.18%-87.3M
Research and development expenses
-9.93%-676.05M
-6.86%-449.7M
-16.81%-207.6M
-8.37%-814.03M
-11.87%-614.98M
-17.51%-420.82M
-26.09%-177.73M
-17.53%-751.18M
-15.65%-549.72M
-30.93%-358.13M
Profit from asset sales
--3.4K
----
--3.4K
----
----
----
----
----
----
----
Revaluation surplus
117.32%5.09M
----
115.54%2.56M
45.13%-29.61M
-25.31%-29.42M
0.19%-23.66M
-155.08%-16.48M
-1,689.02%-53.96M
-76.84%-23.48M
-22.16%-23.71M
-Changes in the fair value of other assets
117.32%5.09M
----
115.54%2.56M
45.13%-29.61M
-25.31%-29.42M
0.19%-23.66M
-155.08%-16.48M
-1,689.02%-53.96M
-76.84%-23.48M
-22.16%-23.71M
Impairment and provision
119.88%136K
121.86%146K
--50.75K
-457.84%-1.5M
-2,211.70%-683.96K
---668K
----
-168.00%-268K
144.03%32.39K
----
-Other impairment is provision
119.88%136K
121.86%146K
--50.75K
-457.84%-1.5M
-2,211.70%-683.96K
---668K
----
-168.00%-268K
144.03%32.39K
----
Special items of operating profit
214.42%72.45M
66.93%130.7M
106.31%16.46M
8.53%164.4M
-10.29%23.04M
263.51%78.3M
-23.51%7.98M
262.94%151.48M
-18.30%25.68M
21.82%-47.89M
Operating profit
67.74%-139.64M
98.84%-2.96M
96.05%-7.09M
31.56%-413.55M
15.62%-432.81M
37.08%-255.92M
-55.37%-179.67M
30.30%-604.24M
3.24%-512.95M
6.63%-406.75M
Financing cost
-49.20%74.95M
-160.11%-27.22M
-30.88%23.49M
3.65%-33.79M
510.93%147.53M
48.56%-10.47M
-66.49%33.98M
-105.74%-35.07M
88.49%-35.9M
-1,356.34%-20.35M
Share of profit from joint venture company
----
73.96%-400K
----
-7.35%-5.26M
----
26.40%-1.54M
----
49.54%-4.9M
----
76.28%-2.09M
Adjustment items of  earning before tax
7,855.69%510.87K
----
----
----
-100.07%-6.59K
----
4,957.94%31K
----
1,703.71%9.57M
----
Earning before tax
77.50%-64.18M
88.59%-30.58M
111.25%16.39M
29.74%-452.59M
47.10%-285.29M
37.57%-267.92M
-923.66%-145.66M
27.92%-644.21M
36.00%-539.29M
3.73%-429.18M
Tax
-27,244.40%-7.77M
-17,331.03%-5.06M
-9,545,052.74%-1.92M
81.56%-263K
---28.42K
---29K
---20.1
---1.43M
----
----
After-tax profit from continuing operations
74.78%-71.95M
86.70%-35.64M
109.94%14.48M
29.86%-452.86M
47.09%-285.32M
37.57%-267.95M
-923.66%-145.66M
27.76%-645.63M
36.00%-539.29M
3.73%-429.18M
Earning after tax
74.78%-71.95M
86.70%-35.64M
109.94%14.48M
29.86%-452.86M
47.09%-285.32M
37.57%-267.95M
-923.66%-145.66M
27.76%-645.63M
36.00%-539.29M
3.73%-429.18M
Minority profit
23.94%-7.54M
9.24%-5.55M
-7.22%-3.49M
14.93%-12.22M
-21.99%-9.91M
12.35%-6.11M
-78.67%-3.26M
-101.42%-14.37M
4.47%-8.12M
-56.03%-6.97M
Profit attributable to shareholders
76.61%-64.41M
88.51%-30.09M
112.62%17.97M
30.20%-440.63M
48.15%-275.41M
37.98%-261.84M
-1,047.82%-142.4M
28.80%-631.26M
36.32%-531.17M
4.33%-422.21M
Basic earnings per share
75.00%-0.04
87.50%-0.02
112.50%0.01
29.73%-0.26
48.39%-0.16
36.00%-0.16
-700.00%-0.08
38.33%-0.37
47.46%-0.31
19.35%-0.25
Diluted earnings per share
75.00%-0.04
87.50%-0.02
112.50%0.01
29.73%-0.26
48.39%-0.16
36.00%-0.16
-700.00%-0.08
38.33%-0.37
47.46%-0.31
19.35%-0.25
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Turnover 59.85%1.12B74.26%731.43M129.92%381.26M36.68%1.01B29.85%697.75M11.17%419.74M-12.44%165.82M18.09%738.54M21.68%537.36M53.50%377.55M
Operating income 59.85%1.12B74.26%731.43M129.92%381.26M36.68%1.01B29.85%697.75M11.17%419.74M-12.44%165.82M18.09%738.54M21.68%537.36M53.50%377.55M
Cost of sales -----27.56%-76.71M-----7.79%-138.44M----20.94%-60.14M----10.43%-128.44M-----21.25%-76.07M
Operating expenses -27.70%-125.18M-27.56%-76.71M-48.48%-36.07M-7.79%-138.44M2.83%-98.03M20.94%-60.14M43.38%-24.29M10.43%-128.44M-1.16%-100.88M-21.25%-76.07M
Gross profit 65.10%990.15M82.07%654.72M143.90%345.2M42.76%871.01M37.40%599.72M19.28%359.6M-3.38%141.53M26.58%610.1M27.67%436.48M64.54%301.48M
Selling expenses -40.77%-385.6M-55.31%-244.07M-27.34%-114.01M-14.46%-419.96M-2.48%-273.93M17.81%-157.15M-4.15%-89.53M16.35%-366.89M7.91%-267.3M-2.77%-191.21M
Administrative expenses -3.33%-130M-3.55%-94.76M-0.83%-42.76M4.99%-183.86M1.66%-125.82M-4.82%-91.51M-14.89%-42.41M-6.59%-193.52M-5.78%-127.94M-11.18%-87.3M
Research and development expenses -9.93%-676.05M-6.86%-449.7M-16.81%-207.6M-8.37%-814.03M-11.87%-614.98M-17.51%-420.82M-26.09%-177.73M-17.53%-751.18M-15.65%-549.72M-30.93%-358.13M
Profit from asset sales --3.4K------3.4K----------------------------
Revaluation surplus 117.32%5.09M----115.54%2.56M45.13%-29.61M-25.31%-29.42M0.19%-23.66M-155.08%-16.48M-1,689.02%-53.96M-76.84%-23.48M-22.16%-23.71M
-Changes in the fair value of other assets 117.32%5.09M----115.54%2.56M45.13%-29.61M-25.31%-29.42M0.19%-23.66M-155.08%-16.48M-1,689.02%-53.96M-76.84%-23.48M-22.16%-23.71M
Impairment and provision 119.88%136K121.86%146K--50.75K-457.84%-1.5M-2,211.70%-683.96K---668K-----168.00%-268K144.03%32.39K----
-Other impairment is provision 119.88%136K121.86%146K--50.75K-457.84%-1.5M-2,211.70%-683.96K---668K-----168.00%-268K144.03%32.39K----
Special items of operating profit 214.42%72.45M66.93%130.7M106.31%16.46M8.53%164.4M-10.29%23.04M263.51%78.3M-23.51%7.98M262.94%151.48M-18.30%25.68M21.82%-47.89M
Operating profit 67.74%-139.64M98.84%-2.96M96.05%-7.09M31.56%-413.55M15.62%-432.81M37.08%-255.92M-55.37%-179.67M30.30%-604.24M3.24%-512.95M6.63%-406.75M
Financing cost -49.20%74.95M-160.11%-27.22M-30.88%23.49M3.65%-33.79M510.93%147.53M48.56%-10.47M-66.49%33.98M-105.74%-35.07M88.49%-35.9M-1,356.34%-20.35M
Share of profit from joint venture company ----73.96%-400K-----7.35%-5.26M----26.40%-1.54M----49.54%-4.9M----76.28%-2.09M
Adjustment items of  earning before tax 7,855.69%510.87K-------------100.07%-6.59K----4,957.94%31K----1,703.71%9.57M----
Earning before tax 77.50%-64.18M88.59%-30.58M111.25%16.39M29.74%-452.59M47.10%-285.29M37.57%-267.92M-923.66%-145.66M27.92%-644.21M36.00%-539.29M3.73%-429.18M
Tax -27,244.40%-7.77M-17,331.03%-5.06M-9,545,052.74%-1.92M81.56%-263K---28.42K---29K---20.1---1.43M--------
After-tax profit from continuing operations 74.78%-71.95M86.70%-35.64M109.94%14.48M29.86%-452.86M47.09%-285.32M37.57%-267.95M-923.66%-145.66M27.76%-645.63M36.00%-539.29M3.73%-429.18M
Earning after tax 74.78%-71.95M86.70%-35.64M109.94%14.48M29.86%-452.86M47.09%-285.32M37.57%-267.95M-923.66%-145.66M27.76%-645.63M36.00%-539.29M3.73%-429.18M
Minority profit 23.94%-7.54M9.24%-5.55M-7.22%-3.49M14.93%-12.22M-21.99%-9.91M12.35%-6.11M-78.67%-3.26M-101.42%-14.37M4.47%-8.12M-56.03%-6.97M
Profit attributable to shareholders 76.61%-64.41M88.51%-30.09M112.62%17.97M30.20%-440.63M48.15%-275.41M37.98%-261.84M-1,047.82%-142.4M28.80%-631.26M36.32%-531.17M4.33%-422.21M
Basic earnings per share 75.00%-0.0487.50%-0.02112.50%0.0129.73%-0.2648.39%-0.1636.00%-0.16-700.00%-0.0838.33%-0.3747.46%-0.3119.35%-0.25
Diluted earnings per share 75.00%-0.0487.50%-0.02112.50%0.0129.73%-0.2648.39%-0.1636.00%-0.16-700.00%-0.0838.33%-0.3747.46%-0.3119.35%-0.25
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
New Consumption Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.88%
Sample Name
Sample Code
 +6.48%
Sample Name
Sample Code
 +4.52%
4
GIANT BIOGENE
02367
+4.07%
5
BLOKS
00325
+2.72%
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More
Are you foolish? What's the point of knowing your mistakes?
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?

- No more -